<DOC>
	<DOCNO>NCT00696813</DOCNO>
	<brief_summary>The purpose non-interventional , observational international registry study document prescribe pattern daily clinical practice ass long term treatment outcomes related initiation treatment oral antipsychotic naturalistic setting .</brief_summary>
	<brief_title>Observational Study Assess Outcomes During Antipsychotic Treatment With Paliperidone ER Other Oral Antipsychotics</brief_title>
	<detailed_description>PILAR non-interventional , observational , international registry use oral antipsychotic naturalistic set patient schizophrenia . Patients initiate new oral antipsychotic treatment candidate documentation registry . All patient treat accord local labeling specification . The overall study objective document prescribe pattern daily clinical practice ass long-term treatment outcome related initiation treatment oral antipsychotic naturalistic setting . The primary objective prospectively document one year treatment outcome healthcare utilization data enable cost-effectiveness analysis paliperidone ER compare oral antipsychotic treatment . Additional objective retrospectively collect data one year , allow evaluation treatment outcomes treatment initiation paliperidone ER oral antipsychotic . Evaluation Adverse Drug Reactions ( ADR ) Serious Adverse Drug Reactions ( SADR ) retrospective period , Adverse Events ( AE ) Serious Adverse Events ( SAE ) prospective period perform report . Dosing administration treatment prescribe physician 's discretion , base approve local label . Dose adjustments medication change make treat physician base clinical judgment usual practice . Subjects receive medication accord usual care treatment setting , study drug provide . The documentation treatment last one year .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnosis schizophrenia Switch start paliperidone ER another oral antipsychotic treatment ( either atypical conventional ) , longer 2 week ago Signed informed consent available begin documentation Able willing fillout selfadministered questionnaire Established treatmentrefractory schizophrenia History neuroleptic malignant syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Registry</keyword>
	<keyword>Healthcare Utilization</keyword>
	<keyword>Outcome</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Cost-effectiveness</keyword>
	<keyword>Paliperidone ER</keyword>
	<keyword>InvegaÂ®</keyword>
	<keyword>Oral antipsychotic</keyword>
</DOC>